Perrigo Pre-Tax Profit Margin 2010-2024 | PRGO
Perrigo pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Perrigo Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $4.39B | $-0.21B | -4.67% |
| 2024-06-30 | $4.43B | $-0.21B | -4.70% |
| 2024-03-31 | $4.56B | $-0.11B | -2.44% |
| 2023-12-31 | $4.66B | $-0.01B | -0.17% |
| 2023-09-30 | $4.65B | $0.03B | 0.69% |
| 2023-06-30 | $4.63B | $0.01B | 0.19% |
| 2023-03-31 | $4.56B | $-0.12B | -2.68% |
| 2022-12-31 | $4.45B | $-0.14B | -3.12% |
| 2022-09-30 | $4.40B | $-0.12B | -2.61% |
| 2022-06-30 | $4.35B | $0.28B | 6.40% |
| 2022-03-31 | $4.20B | $0.23B | 5.45% |
| 2021-12-31 | $4.14B | $0.26B | 6.26% |
| 2021-09-30 | $4.09B | $0.13B | 3.28% |
| 2021-06-30 | $4.05B | $-0.21B | -5.11% |
| 2021-03-31 | $4.02B | $-0.03B | -0.85% |
| 2020-12-31 | $4.09B | $0.01B | 0.15% |
| 2020-09-30 | $3.39B | $0.06B | 1.89% |
| 2020-06-30 | $3.58B | $0.11B | 3.16% |
| 2020-03-31 | $3.78B | $0.12B | 3.28% |
| 2019-12-31 | $3.87B | $0.15B | 3.82% |
| 2019-09-30 | $4.71B | $0.41B | 8.68% |
| 2019-06-30 | $4.65B | $0.23B | 5.01% |
| 2019-03-31 | $4.69B | $0.26B | 5.57% |
| 2018-12-31 | $4.73B | $0.29B | 6.15% |
| 2018-09-30 | $4.82B | $0.22B | 4.54% |
| 2018-06-30 | $4.92B | $0.43B | 8.68% |
| 2018-03-31 | $4.97B | $0.30B | 5.96% |
| 2017-12-31 | $4.95B | $0.28B | 5.68% |
| 2017-09-30 | $4.99B | $-1.50B | -29.94% |
| 2017-06-30 | $5.03B | $-3.53B | -70.17% |
| 2017-03-31 | $5.13B | $-4.26B | -83.11% |
| 2016-12-31 | $5.28B | $-4.85B | -91.80% |
| 2016-09-30 | $2.93B | $-3.54B | -120.94% |
| 2016-06-30 | $2.94B | $-1.34B | -45.71% |
| 2015-12-31 | $1.22B | $0.01B | 0.82% |
| 2015-09-30 | $3.31B | $0.43B | 13.01% |
| 2014-12-31 | $3.03B | $0.26B | 8.49% |
| 2014-09-30 | $2.94B | $0.06B | 2.01% |
| 2013-12-31 | $2.83B | $0.20B | 7.20% |
| 2013-09-30 | $2.74B | $0.46B | 16.92% |
| 2012-12-31 | $2.43B | $0.42B | 17.36% |
| 2012-09-30 | $2.39B | $0.42B | 17.60% |
| 2011-12-31 | $2.26B | $0.35B | 15.34% |
| 2011-09-30 | $2.14B | $0.32B | 15.18% |
| 2010-12-31 | $1.90B | $0.31B | 16.29% |
| 2010-09-30 | $1.76B | $0.28B | 15.96% |
| 2009-12-31 | $1.62B | $0.22B | 13.80% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.281B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.284B | 25.22 |
| Stryker (SYK) | United States | $148.861B | 33.55 |
| Boston Scientific (BSX) | United States | $147.840B | 42.50 |
| EssilorLuxottica (ESLOY) | France | $120.398B | 0.00 |
| Medtronic (MDT) | Ireland | $112.636B | 16.73 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.153B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.736B | 27.12 |
| GE HealthCare Technologies (GEHC) | United States | $39.899B | 20.69 |
| ResMed (RMD) | United States | $36.307B | 29.83 |
| Terumo (TRUMY) | Japan | $28.860B | 40.76 |
| Koninklijke Philips (PHG) | Netherlands | $24.692B | 18.90 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.842B | 13.91 |
| Insulet (PODD) | United States | $19.563B | 77.90 |
| Baxter (BAX) | United States | $16.252B | 10.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.094B | 34.30 |
| BellRing Brands (BRBR) | United States | $9.817B | 39.50 |
| Demant (WILYY) | Denmark | $8.735B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.632B | 15.41 |
| ICU Medical (ICUI) | United States | $4.089B | 38.93 |
| Prestige Consumer Healthcare (PBH) | United States | $3.823B | 19.01 |
| Haemonetics (HAE) | United States | $3.684B | 17.98 |
| Envista Holdings (NVST) | United States | $3.623B | 26.99 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.992B | 19.25 |
| GN Store Nord (GNNDY) | Denmark | $2.797B | 17.94 |
| Neogen (NEOG) | United States | $2.592B | 29.88 |
| LeMaitre Vascular (LMAT) | United States | $2.203B | 53.55 |
| AtriCure (ATRC) | United States | $1.926B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.514B | 26.50 |
| InMode (INMD) | Israel | $1.434B | 8.62 |
| AdaptHealth (AHCO) | United States | $1.368B | 9.78 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.343B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.274B | 0.00 |
| Owens & Minor (OMI) | United States | $1.145B | 8.95 |
| Curaleaf Holdings (CURLF) | Canada | $0.903B | 0.00 |
| Evolus (EOLS) | United States | $0.895B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.881B | 15.54 |
| CeriBell (CBLL) | United States | $0.833B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.678B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.572B | 25.24 |
| Omeros (OMER) | United States | $0.538B | 0.00 |
| Surmodics (SRDX) | United States | $0.530B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.434B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.418B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.91 |
| Quanterix (QTRX) | United States | $0.386B | 0.00 |
| Valneva SE (VALN) | France | $0.376B | 0.00 |
| Cerus (CERS) | United States | $0.336B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Biote (BTMD) | United States | $0.307B | 6.73 |
| OraSure Technologies (OSUR) | United States | $0.290B | 19.45 |
| Canopy Growth (CGC) | Canada | $0.263B | 0.00 |
| Zynex (ZYXI) | United States | $0.261B | 54.53 |
| High Tide (HITI) | Canada | $0.244B | 100.33 |
| Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.71 |
| Aurora Cannabis (ACB) | Canada | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 110.50 |
| Organigram Holdings (OGI) | Canada | $0.198B | 0.00 |
| MacroGenics (MGNX) | United States | $0.193B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.153B | 0.00 |
| Veru (VERU) | United States | $0.152B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 18.29 |
| Jin Medical (ZJYL) | China | $0.136B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 11.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| InterCure (INCR) | Israel | $0.078B | 0.00 |
| INLIF (INLF) | $0.074B | 0.00 | |
| Exagen (XGN) | United States | $0.071B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 36.33 |
| Apyx Medical (APYX) | United States | $0.057B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.017B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 14.07 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |